tiprankstipranks
Trending News
More News >

JOINN Laboratories Expands Financial Investments with CITIC Securities

Story Highlights
  • JOINN Laboratories subscribed to CITIC Securities financial products worth RMB400,000,000.
  • This transaction is a discloseable event under Hong Kong Listing Rules due to percentage ratios.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
JOINN Laboratories Expands Financial Investments with CITIC Securities

JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has issued an update.

JOINN Laboratories (China) Co., Ltd. announced that it has subscribed to further financial products from CITIC Securities, with an outstanding investment amount of RMB400,000,000. This transaction is classified as a discloseable transaction under the Hong Kong Listing Rules, as the applicable percentage ratios exceed 5% but are below 25%, necessitating notification and announcement requirements. The company expects reasonable returns from these investments and confirms that this subscription will not adversely affect its financial position.

More about JOINN Laboratories (China) Co., Ltd. Class H

JOINN Laboratories (China) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the financial sector. The company engages in the subscription of financial products, focusing on investments through CITIC Securities and its subsidiaries.

YTD Price Performance: 9.30%

Average Trading Volume: 3,783,468

Technical Sentiment Signal: Buy

Current Market Cap: HK$11.91B

For detailed information about 6127 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App